Cargando…
Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
PURPOSE: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. MATERIALS AND METHODS: Patterns-of-care in SBRT using RTRT for histologically p...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217432/ https://www.ncbi.nlm.nih.gov/pubmed/28057036 http://dx.doi.org/10.1186/s13014-016-0742-3 |
_version_ | 1782492109936263168 |
---|---|
author | Katoh, Norio Soda, Itaru Tamamura, Hiroyasu Takahashi, Shotaro Uchinami, Yusuke Ishiyama, Hiromichi Ota, Kiyotaka Inoue, Tetsuya Onimaru, Rikiya Shibuya, Keiko Hayakawa, Kazushige Shirato, Hiroki |
author_facet | Katoh, Norio Soda, Itaru Tamamura, Hiroyasu Takahashi, Shotaro Uchinami, Yusuke Ishiyama, Hiromichi Ota, Kiyotaka Inoue, Tetsuya Onimaru, Rikiya Shibuya, Keiko Hayakawa, Kazushige Shirato, Hiroki |
author_sort | Katoh, Norio |
collection | PubMed |
description | PURPOSE: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. MATERIALS AND METHODS: Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. RESULTS: From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52–90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (10) at the isocenter using the linear-quadratic model was from 66 Gy to 126 Gy with a median of 106 Gy. With a median follow-up period of 28 months (range 0–127), the overall survival rate for the entire group, for stage IA, and for stage IB + IIA was 75%, 79%, and 65% at 2 years, and 64%, 70%, and 50% at 3 years, respectively. In the multivariate analysis, the favorable predictive factor was female for overall survival. There were no differences between the clinical outcomes at the four institutions. Grade 2, 3, 4, and 5 radiation pneumonitis was experienced by 29 (10.2%), 9 (3.2%), 0, and 0 patients. The subgroup analyses revealed that compared to margins from gross tumor volume (GTV) to planning target volume (PTV) ≥ 10 mm, margins < 10 mm did not worsen the overall survival and local control rates, while reducing the risk of radiation pneumonitis. CONCLUSIONS: This multi-institutional retrospective study showed that the results were consistent with the recent patterns-of-care and patterns-of-outcome analysis of SBRT. A prospective study will be required to evaluate SBRT using a RTRT system with margins from GTV to PTV < 10mm. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-016-0742-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5217432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52174322017-01-09 Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system Katoh, Norio Soda, Itaru Tamamura, Hiroyasu Takahashi, Shotaro Uchinami, Yusuke Ishiyama, Hiromichi Ota, Kiyotaka Inoue, Tetsuya Onimaru, Rikiya Shibuya, Keiko Hayakawa, Kazushige Shirato, Hiroki Radiat Oncol Research PURPOSE: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. MATERIALS AND METHODS: Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. RESULTS: From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52–90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (10) at the isocenter using the linear-quadratic model was from 66 Gy to 126 Gy with a median of 106 Gy. With a median follow-up period of 28 months (range 0–127), the overall survival rate for the entire group, for stage IA, and for stage IB + IIA was 75%, 79%, and 65% at 2 years, and 64%, 70%, and 50% at 3 years, respectively. In the multivariate analysis, the favorable predictive factor was female for overall survival. There were no differences between the clinical outcomes at the four institutions. Grade 2, 3, 4, and 5 radiation pneumonitis was experienced by 29 (10.2%), 9 (3.2%), 0, and 0 patients. The subgroup analyses revealed that compared to margins from gross tumor volume (GTV) to planning target volume (PTV) ≥ 10 mm, margins < 10 mm did not worsen the overall survival and local control rates, while reducing the risk of radiation pneumonitis. CONCLUSIONS: This multi-institutional retrospective study showed that the results were consistent with the recent patterns-of-care and patterns-of-outcome analysis of SBRT. A prospective study will be required to evaluate SBRT using a RTRT system with margins from GTV to PTV < 10mm. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-016-0742-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-05 /pmc/articles/PMC5217432/ /pubmed/28057036 http://dx.doi.org/10.1186/s13014-016-0742-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Katoh, Norio Soda, Itaru Tamamura, Hiroyasu Takahashi, Shotaro Uchinami, Yusuke Ishiyama, Hiromichi Ota, Kiyotaka Inoue, Tetsuya Onimaru, Rikiya Shibuya, Keiko Hayakawa, Kazushige Shirato, Hiroki Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
title | Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
title_full | Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
title_fullStr | Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
title_full_unstemmed | Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
title_short | Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
title_sort | clinical outcomes of stage i and iia non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217432/ https://www.ncbi.nlm.nih.gov/pubmed/28057036 http://dx.doi.org/10.1186/s13014-016-0742-3 |
work_keys_str_mv | AT katohnorio clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT sodaitaru clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT tamamurahiroyasu clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT takahashishotaro clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT uchinamiyusuke clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT ishiyamahiromichi clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT otakiyotaka clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT inouetetsuya clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT onimarurikiya clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT shibuyakeiko clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT hayakawakazushige clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem AT shiratohiroki clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem |